- Home
- GEO vs RNA Comparison
GEO vs RNA Comparison
Compare GEO & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GEO | RNA |
|---|---|---|
| Founded | 1984 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 4.0B |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | GEO | RNA |
|---|---|---|
| Price | $17.22 | $71.76 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 20 |
| Target Price | $41.00 | ★ $69.26 |
| AVG Volume (30 Days) | 1.9M | ★ 2.9M |
| Earning Date | 11-06-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 515.49 | N/A |
| EPS | ★ 1.69 | N/A |
| Revenue | ★ $2,531,574,000.00 | $20,868,000.00 |
| Revenue This Year | $7.93 | $64.11 |
| Revenue Next Year | $15.02 | $37.25 |
| P/E Ratio | $10.14 | ★ N/A |
| Revenue Growth | 4.43 | ★ 106.27 |
| 52 Week Low | $14.27 | $21.51 |
| 52 Week High | $36.46 | $71.79 |
Technical Indicators
Market Signals| Indicator | GEO | RNA |
|---|---|---|
| Relative Strength Index (RSI) | 62.45 | 77.56 |
| Support Level | $15.47 | $71.42 |
| Resistance Level | $15.91 | $71.76 |
| Average True Range (ATR) | 0.54 | 0.41 |
| MACD | 0.38 | -0.73 |
| Stochastic Oscillator | 93.62 | 88.32 |
Price Performance
Historical ComparisonAbout GEO Geo Group Inc (The) REIT
The GEO Group Inc specializes in detention facilities and community reentry centers. It operates in four segments: U.S. Secure Services, which mainly encompasses U.S.-based secure services business; Electronic Monitoring and Supervision Services, which conducts its services in the United States, represents services provided to adults for monitoring services and evidence-based supervision and treatment programs for community-based parolees, probationers, and pretrial defendants; Reentry Services conducts its services in the United States represents services provided to adults for residential and non-residential treatment, educational and community-based programs, pre-release and half-way house programs; and International Services.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.